CYTOKINETICS INCORPOR
50.25
25-November-24 15:45:01
15 minutes delayed
Stocks
+1.15
+2.34%
Today's range
49.45 - 51.11
ISIN
N/A
Source
NASDAQ
-
Cytokinetics Reports Second Quarter 2022 Financial Results
04 Aug 2022 15:00:00 By Nasdaq GlobeNewswire
-
04 Aug 2022 06:30:01 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Aug 2022 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce Second Quarter Results on August 4, 2022
21 Jul 2022 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
05 Jul 2022 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Pricing of $450 Million Convertible Senior Notes Offering
01 Jul 2022 02:35:20 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Proposed Convertible Senior Notes Offering
29 Jun 2022 15:35:18 By Nasdaq GlobeNewswire
-
24 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Provides Regulatory Update for Omecamtiv Mecarbil
17 Jun 2022 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing COURAGE-ALS
16 Jun 2022 06:30:00 By Nasdaq GlobeNewswire